Incidence of diabetes and gout in hypertensive patients during 8 years of follow-up

Journal of Human Hypertension

Volumn 11, Issue 9, 1997, Pages 583-585

  Grodzicki, T ^a,b   Palmer, A ^a   Bulpitt, C J ^a,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Diabetes mellitus; Diuretics; Gout; Hypertension

Indexed keywords

DIURETIC AGENT;

ARTICLE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DIURETIC THERAPY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; GOUT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RISK; SCREENING;

EID: 0030669238     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000496     Document Type: Article

References (20)

1. Tan MH, Maclean DR. Epidemiology of diabetes mellitus in Canada. Clin Invest Med 1995; 18: 240-246.
2. el Mugamer IT, Ali Zayat AS, Hossain MM, Pugh RN. Diabetes, obesity and hypertension in urban and rural people of bedouin origin in the United Arab Emirates. J Trop Med Hyg 1995; 98: 407-415.
3. Duncan B et al. Association of fasting insulin with clustering of metabolic disturbances in African Americans and Whites (abstract). Diabetes 1994; 43: (Suppl 1): 150A.
4. Haffner SM. Epidemiology of hypertension and insulin resistance syndrome. J Hypertens 1997; 15 (Suppl 1): S25-S30.
5. Levy D, Kannel WB. Cardiovascular risks: new insights from Framingham. Am Heart J 1988; 116: 266-272.
6. Fletcher A et al. Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly. J Hypertens 1991; 9: 225-230.
7. Pickkers P, Schachter M, Sever PS, Hughes AD. Do KCa channels and carbonic anhydrase play a role in thiazide-induced hyperglycaemia? J Hum Hypertens 1995; 9: 691-693.
8. Hermansen K, Schmitz O, Mogensen CE. Effects of a thiazide diuretic (hydroflumethiazide) and a loop diuretic (bumetanide) on the endocrine pancreas: studies in vitro. Metabolism 1985; 34: 784-789.
9. Mayhew SR. Hypertension screening in general practice. Report on behalf of the General Practitioner Hypertension Study Group. JR Coll Gen Pract 1983; 33: 434-437.
10. Lind L, Pollare T, Berne C, Lithell H. Long-term metabolic effects of antihypertensive drugs. Am Heart J 1994; 128: 1177-1183.
11. Curzio JL et al. Risk factor modification in hypertension-success and failure. J Hum Hypertens 1987; 1: 131-136.
12. Harper R et al. A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM. Diabetologia 1995; 38: 853-859.
13. Amery A et al. Glucose intolerance during diuretic therapy in elderly hypertensive patients. A second report from the European Working Party on high blood pressure in the elderly (EWPHE). Postgrad Med J 1986; 62: 919-924.
14. Helderman JH et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 1983; 32: 106-111.
15. Langford HG et al. The effect of thiazide therapy on glucose, insulin and cholesterol metabolism and of glucose on potassium: results of a cross-sectional study in patients from the Hypertension Detection and Follow-up Program. J Hum Hypertens 1990; 4: 491-500.
16. Tykarski A. Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron 1991; 59(3): 364-368.
17. Bulpitt CJ. Serum uric acid in hypertensive patients. Br Heart J 1975; 37: 1210-1215.
18. Bywaters EGL, Glynn LE. Connective tissue disorders. In: Thompson RHS, Wootton IDP (eds) Biochemical Disorders in Human Disease, 3rd edn. Churchill: London, 1970, p 735.
19. Dueymes JM. Clinical update: spironolactone and altizide as monotherapy in systemic hypertension. Am J Cardiol 1990; 65: 20K-23K.
20. Plante GE, Dessurault DL. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide. Am J Med 1988; 84: 98-103.